{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T05:40:25Z","timestamp":1785649225755,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"STI2030-Major Projects","award":["2022ZD0213800"],"award-info":[{"award-number":["2022ZD0213800"]}]},{"name":"the National Science Foundation of China","award":["81801752, 82171473, 82201583, 82071962, 81971674"],"award-info":[{"award-number":["81801752, 82171473, 82201583, 82071962, 81971674"]}]},{"name":"the Shanghai Sailing Program","award":["18YF1403200, 19YF1405300"],"award-info":[{"award-number":["18YF1403200, 19YF1405300"]}]},{"name":"the startup fund of Huashan Hospital, Fudan University","award":["2017QD081"],"award-info":[{"award-number":["2017QD081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00259-025-07080-x","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T09:02:16Z","timestamp":1737450136000},"page":"1481-1495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of objective subtle cognitive difficulties with amyloid-\u03b2 and tau deposition compared to subjective cognitive decline"],"prefix":"10.1007","volume":"52","author":[{"given":"Xiaoxie","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2667-281X","authenticated-orcid":false,"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"7080_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of alzheimer\u2019s disease: Recommendations from the national institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7:280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","journal-title":"Alzheimers Dement"},{"key":"7080_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12:292\u2013323. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.002.","journal-title":"Alzheimers Dement"},{"key":"7080_CR3","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement (N Y). 2020;6:e12050. https:\/\/doi.org\/10.1002\/trc2.12050.","journal-title":"Alzheimers Dement (N Y)"},{"key":"7080_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2014;10:844\u201352. https:\/\/doi.org\/10.1016\/j.jalz.2014.01.001.","journal-title":"Alzheimers Dement"},{"key":"7080_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jad.2019.08.082","volume":"260","author":"JE Lee","year":"2020","unstructured":"Lee JE, Ju YJ, Park EC, Lee SY. Effect of poor sleep quality on subjective cognitive decline (SCD) or SCD-related functional difficulties: results from 220,000 nationwide general populations without dementia. J Affect Disord. 2020;260:32\u20137. https:\/\/doi.org\/10.1016\/j.jad.2019.08.082.","journal-title":"J Affect Disord"},{"key":"7080_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13195-022-01138-w","volume":"14","author":"MD Oliver","year":"2022","unstructured":"Oliver MD, Morrison C, Kamal F, Graham J, Dadar M. Subjective cognitive decline is a better marker for future cognitive decline in females than in males. Alzheimers Res Ther. 2022;14:197. https:\/\/doi.org\/10.1186\/s13195-022-01138-w.","journal-title":"Alzheimers Res Ther"},{"key":"7080_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-180229","volume":"64","author":"KR Thomas","year":"2018","unstructured":"Thomas KR, Edmonds EC, Eppig J, Salmon DP, Bondi MW. Alzheimer\u2019s disease neuroimaging I. using neuropsychological process scores to identify subtle cognitive decline and predict progression to mild cognitive impairment. J Alzheimers Dis. 2018;64:195\u2013204. https:\/\/doi.org\/10.3233\/JAD-180229.","journal-title":"J Alzheimers Dis"},{"key":"7080_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-150128","volume":"47","author":"EC Edmonds","year":"2015","unstructured":"Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. Alzheimer\u2019s disease neuroimaging I. subtle cognitive decline and biomarker staging in preclinical alzheimer\u2019s disease. J Alzheimers Dis. 2015;47:231\u201342. https:\/\/doi.org\/10.3233\/JAD-150128.","journal-title":"J Alzheimers Dis"},{"key":"7080_CR9","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1212\/wnl.0000000000008838","volume":"94","author":"KR Thomas","year":"2020","unstructured":"Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Wong CG, Cooper S, et al. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology. 2020;94:e397\u2013406. https:\/\/doi.org\/10.1212\/wnl.0000000000008838.","journal-title":"Neurology"},{"key":"7080_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2023.01.004","volume":"513","author":"S Ren","year":"2023","unstructured":"Ren S, Li J, Huang L, Huang Q, Chen K, Hu J, et al. Brain functional alterations and association with cognition in people with preclinical subjective Cognitive decline and objective subtle cognitive difficulties. Neuroscience. 2023;513:137\u201344. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.01.004.","journal-title":"Neuroscience"},{"key":"7080_CR11","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/cns.13962","volume":"28","author":"Y Huang","year":"2022","unstructured":"Huang Y, Li Y, Xie F, Guo Q. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients. CNS Neurosci Ther. 2022;28:2195\u2013205. https:\/\/doi.org\/10.1111\/cns.13962.","journal-title":"CNS Neurosci Ther"},{"key":"7080_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00415-020-10163-4","volume":"268","author":"JD Jones","year":"2021","unstructured":"Jones JD, Uribe C, Bunch J, Thomas KR, Beyond. PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes. J Neurol. 2021;268:337\u201345. https:\/\/doi.org\/10.1007\/s00415-020-10163-4.","journal-title":"J Neurol"},{"key":"7080_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1037\/neu0000413","volume":"32","author":"KR Thomas","year":"2018","unstructured":"Thomas KR, Eppig J, Edmonds EC, Jacobs DM, Libon DJ, Au R, et al. Word-list intrusion errors predict progression to mild cognitive impairment. Neuropsychology. 2018;32:235\u201345. https:\/\/doi.org\/10.1037\/neu0000413.","journal-title":"Neuropsychology"},{"key":"7080_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, G\u00f6tz J. Amyloid-\u03b2 and tau \u2014 a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci. 2010;12:67\u201372. https:\/\/doi.org\/10.1038\/nrn2967.","journal-title":"Nat Rev Neurosci"},{"key":"7080_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"L Spires-Jones Tara","year":"2014","unstructured":"Spires-Jones Tara L, Hyman Bradley T. The intersection of amyloid Beta and tau at synapses in Alzheimer\u2019s Disease. Neuron. 2014;82:756\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2014.05.004.","journal-title":"Neuron"},{"key":"7080_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367:795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753.","journal-title":"N Engl J Med"},{"key":"7080_CR17","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jamaneurol.2017.2216","volume":"74","author":"RF Buckley","year":"2017","unstructured":"Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, et al. Region-specific association of subjective cognitive decline with tauopathy independent of global beta-amyloid Burden. JAMA Neurol. 2017;74:1455\u201363. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2216.","journal-title":"JAMA Neurol"},{"key":"7080_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13195-022-01060-1","volume":"14","author":"KR Thomas","year":"2022","unstructured":"Thomas KR, Weigand AJ, Edwards LC, Edmonds EC, Bangen KJ, Ortiz G, et al. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint. Alzheimers Res Ther. 2022;14:114. https:\/\/doi.org\/10.1186\/s13195-022-01060-1.","journal-title":"Alzheimers Res Ther"},{"key":"7080_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/alz.13355","volume":"20","author":"C Boccalini","year":"2024","unstructured":"Boccalini C, Ribaldi F, Hristovska I, Arnone A, Peretti DE, Mu L, et al. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimers Dement. 2024;20:221\u201333. https:\/\/doi.org\/10.1002\/alz.13355.","journal-title":"Alzheimers Dement"},{"key":"7080_CR20","doi-asserted-by":"publisher","unstructured":"Biel D, Brendel M, Rubinski A, Buerger K, Janowitz D, Dichgans M, et al. Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals. Alzheimers Res Ther. 2021;13. https:\/\/doi.org\/10.1186\/s13195-021-00880-x.","DOI":"10.1186\/s13195-021-00880-x"},{"key":"7080_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jalz.2015.05.004","volume":"11","author":"LA Beckett","year":"2015","unstructured":"Beckett LA, Donohue MC, Wang C, Aisen P, Harvey DJ, Saito N. The alzheimer\u2019s disease neuroimaging initiative phase 2: increasing the length, breadth, and depth of our understanding. Alzheimers Dement. 2015;11:823\u201331. https:\/\/doi.org\/10.1016\/j.jalz.2015.05.004.","journal-title":"Alzheimers Dement"},{"key":"7080_CR22","doi-asserted-by":"publisher","first-page":"e12238","DOI":"10.1002\/dad2.12238","volume":"13","author":"KR Thomas","year":"2021","unstructured":"Thomas KR, Bangen KJ, Edmonds EC, Weigand AJ, Walker KS, Bondi MW, et al. Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of alzheimer\u2019s disease-related declines. Alzheimers Dement (Amst). 2021;13:e12238. https:\/\/doi.org\/10.1002\/dad2.12238.","journal-title":"Alzheimers Dement (Amst)"},{"key":"7080_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02501-z","author":"J Wang","year":"2024","unstructured":"Wang J, Huang Q, Chen X, You Z, He K, Guo Q, et al. Tau pathology is associated with synaptic density and longitudinal synaptic loss in alzheimer\u2019s disease. Mol Psychiatry. 2024. https:\/\/doi.org\/10.1038\/s41380-024-02501-z.","journal-title":"Mol Psychiatry"},{"key":"7080_CR24","doi-asserted-by":"publisher","unstructured":"Chen T, Pan F, Huang Q, Xie G, Chao X, Wu L, et al. Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer\u2019s disease. Nat Commun. 2024;15. https:\/\/doi.org\/10.1038\/s41467-024-47897-y.","DOI":"10.1038\/s41467-024-47897-y"},{"issue":"1","key":"7080_CR25","doi-asserted-by":"publisher","first-page":"e12072","DOI":"10.1002\/trc2.12072","volume":"6","author":"SE Choi","year":"2020","unstructured":"Choi SE, Mukherjee S, Gibbons LE, Sanders RE, Jones RN, Tommet D, et al. Development and validation of language and visuospatial composite scores in ADNI. Alzheimer\u2019s Dementia: Translational Res Clin Interventions. 2020;6(1):e12072. https:\/\/doi.org\/10.1002\/trc2.12072.","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"key":"7080_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3233\/JAD-221166","volume":"94","author":"J Wang","year":"2023","unstructured":"Wang J, Wang M, Ren S, Huang L, He K, Li J, et al. The effect of gender and APOE varepsilon4 status on brain amyloid-beta deposition in different age groups of mild cognitively impaired individuals: a PET-CT study. J Alzheimers Dis. 2023;94:763\u201375. https:\/\/doi.org\/10.3233\/JAD-221166.","journal-title":"J Alzheimers Dis"},{"key":"7080_CR27","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1002\/alz.13775","volume":"20","author":"K He","year":"2024","unstructured":"He K, Li B, Wang J, Wang Y, You Z, Chen X, et al. APOE \u03b54 is associated with decreased synaptic density in cognitively impaired participants. Alzheimer\u2019s Dement. 2024;20:3157\u201366. https:\/\/doi.org\/10.1002\/alz.13775.","journal-title":"Alzheimer\u2019s Dement"},{"key":"7080_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00406-019-01083-0","volume":"270","author":"Q Huang","year":"2020","unstructured":"Huang Q, Ren S, Jiang D, Guan Y, Xie F, Sun D, et al. Changes in brain glucose metabolism and connectivity in somatoform disorders: an (18)F-FDG PET study. Eur Arch Psychiatry Clin Neurosci. 2020;270:881\u201391. https:\/\/doi.org\/10.1007\/s00406-019-01083-0.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"7080_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuroscience.2019.07.048","volume":"417","author":"J Su","year":"2019","unstructured":"Su J, Huang Q, Ren S, Xie F, Zhai Y, Guan Y, et al. Altered brain glucose metabolism assessed by (18)F-FDG PET imaging is Associated with the cognitive impairment of CADASIL. Neuroscience. 2019;417:35\u201344. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.07.048.","journal-title":"Neuroscience"},{"key":"7080_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","volume":"56","author":"SM Landau","year":"2015","unstructured":"Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, et al. Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015;56:567\u201374. https:\/\/doi.org\/10.2967\/jnumed.114.148981.","journal-title":"J Nucl Med"},{"key":"7080_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann A, Tian L, Henderson VW, Greicius MD. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75:563\u201373. https:\/\/doi.org\/10.1002\/ana.24135.","journal-title":"Ann Neurol"},{"key":"7080_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359. https:\/\/doi.org\/10.1007\/bf00308809.","journal-title":"Acta Neuropathol"},{"key":"7080_CR33","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/wnl.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91:e859\u201366. https:\/\/doi.org\/10.1212\/wnl.0000000000006075.","journal-title":"Neurology"},{"key":"7080_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/jneurosci.2028-17.2017","volume":"38","author":"A Maass","year":"2018","unstructured":"Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, et al. Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J Neurosci. 2018;38:530\u201343. https:\/\/doi.org\/10.1523\/jneurosci.2028-17.2017.","journal-title":"J Neurosci"},{"key":"7080_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z.","journal-title":"Acta Neuropathol"},{"key":"7080_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/jad-130098","volume":"38","author":"DT Chien","year":"2014","unstructured":"Chien DT, Szardenings AK, Bahri S, Walsh JC, Mu F, Xia C, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. J Alzheimers Dis. 2014;38:171\u201384. https:\/\/doi.org\/10.3233\/jad-130098.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"7080_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","volume":"80","author":"J Therriault","year":"2023","unstructured":"Therriault J, Vermeiren M, Servaes S, Tissot C, Ashton NJ, Benedet AL, et al. Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol. 2023;80(2):188\u2013199. https:\/\/doi.org\/10.1001\/jamaneurol.2022.4485.","journal-title":"JAMA Neurol"},{"key":"7080_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, et al. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry. 2019;24:1112\u201334. https:\/\/doi.org\/10.1038\/s41380-018-0342-8.","journal-title":"Mol Psychiatry"},{"key":"7080_CR39","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00259-021-05401-4","volume":"48","author":"A Leuzy","year":"2021","unstructured":"Leuzy A, Pascoal TA, Strandberg O, Insel P, Smith R, Mattsson-Carlgren N, et al. A multicenter comparison of [(18)F]flortaucipir, [(18)F]RO948, and [(18)F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging. 2021;48:2295\u2013305. https:\/\/doi.org\/10.1007\/s00259-021-05401-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7080_CR40","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267539","author":"A Aliaga","year":"2024","unstructured":"Aliaga A, Therriault J, Quispialaya KM, Aliaga A, Hopewell R, Rahmouni N, et al. Comparison between brain and cerebellar autoradiography using [(18)F]Flortaucipir, [(18)F]MK6240, and [(18)F]PI2620 in postmortem human brain tissue. J Nucl Med. 2024. https:\/\/doi.org\/10.2967\/jnumed.124.267539.","journal-title":"J Nucl Med"},{"key":"7080_CR41","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jalz.2015.03.003","volume":"11","author":"SL Risacher","year":"2015","unstructured":"Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, et al. APOE effect on alzheimer\u2019s disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015;11:1417\u201329. https:\/\/doi.org\/10.1016\/j.jalz.2015.03.003.","journal-title":"Alzheimers Dement"},{"key":"7080_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1212\/01.wnl.0000234032.77541.a2","volume":"67","author":"AJ Saykin","year":"2006","unstructured":"Saykin AJ, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology. 2006;67:834\u201342. https:\/\/doi.org\/10.1212\/01.wnl.0000234032.77541.a2.","journal-title":"Neurology"},{"key":"7080_CR43","doi-asserted-by":"publisher","first-page":"102923","DOI":"10.1016\/j.nicl.2021.102923","volume":"33","author":"C Morrison","year":"2022","unstructured":"Morrison C, Dadar M, Shafiee N, Villeneuve S, Louis Collins D. Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline. Neuroimage Clin. 2022;33:102923. https:\/\/doi.org\/10.1016\/j.nicl.2021.102923.","journal-title":"Neuroimage Clin"},{"key":"7080_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.eurpsy.2008.02.004","volume":"23","author":"K Abdulrab","year":"2008","unstructured":"Abdulrab K, Heun R. Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry. 2008;23:321\u201330. https:\/\/doi.org\/10.1016\/j.eurpsy.2008.02.004.","journal-title":"Eur Psychiatry"},{"key":"7080_CR45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jalz.2016.09.012","volume":"13","author":"JL Molinuevo","year":"2017","unstructured":"Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017;13:296\u2013311. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.012.","journal-title":"Alzheimers Dement"},{"key":"7080_CR46","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/brain\/aww334","volume":"140","author":"MJ Pontecorvo","year":"2017","unstructured":"Pontecorvo MJ, Devous MD, Sr., Navitsky M, Lu M, Salloway S, Schaerf FW, et al. Relationships between Flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain. 2017;140:748\u201363. https:\/\/doi.org\/10.1093\/brain\/aww334.","journal-title":"Brain"},{"key":"7080_CR47","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139:1551\u201367. https:\/\/doi.org\/10.1093\/brain\/aww027.","journal-title":"Brain"},{"key":"7080_CR48","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in alzheimer\u2019s disease. Brain. 2017;140:3286\u2013300. https:\/\/doi.org\/10.1093\/brain\/awx243.","journal-title":"Brain"},{"key":"7080_CR49","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","volume":"84","author":"R Sperling","year":"2014","unstructured":"Sperling R, Mormino E, Johnson K. The evolution of preclinical alzheimer\u2019s disease: Implications for prevention trials. Neuron. 2014;84:608\u201322. https:\/\/doi.org\/10.1016\/j.neuron.2014.10.038.","journal-title":"Neuron"},{"key":"7080_CR50","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaneurol.2023.4038","volume":"80","author":"A Steward","year":"2023","unstructured":"Steward A, Biel D, Dewenter A, Roemer S, Wagner F, Dehsarvi A, et al. ApoE4 and connectivity-mediated spreading of tau pathology at lower amyloid levels. JAMA Neurol. 2023;80:1295\u2013306. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4038.","journal-title":"JAMA Neurol"},{"key":"7080_CR51","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart Samuel N, Schonhaut Daniel R, O\u2019Neil James P, Janabi M, Ossenkoppele R, et al. PET imaging of tau deposition in the aging human brain. Neuron. 2016;89:971\u201382. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.028.","journal-title":"Neuron"},{"key":"7080_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-\u03b2 plaques enhance alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29\u201338. https:\/\/doi.org\/10.1038\/nm.4443.","journal-title":"Nat Med"},{"key":"7080_CR53","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT, et al. Four distinct trajectories of tau deposition identified in alzheimer\u2019s disease. Nat Med. 2021;27:871\u201381. https:\/\/doi.org\/10.1038\/s41591-021-01309-6.","journal-title":"Nat Med"},{"key":"7080_CR54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol. 2023;19:715\u201336. https:\/\/doi.org\/10.1038\/s41582-023-00883-2.","journal-title":"Nat Rev Neurol"},{"key":"7080_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15:73\u201388. https:\/\/doi.org\/10.1038\/s41582-018-0116-6.","journal-title":"Nat Rev Neurol"},{"key":"7080_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archneurol.2011.559","volume":"69","author":"GW Small","year":"2012","unstructured":"Small GW, Siddarth P, Kepe V, Ercoli LM, Burggren AC, Bookheimer SY, et al. Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. Arch Neurol. 2012;69:215\u201322. https:\/\/doi.org\/10.1001\/archneurol.2011.559.","journal-title":"Arch Neurol"},{"key":"7080_CR57","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","volume":"79","author":"PM Doraiswamy","year":"2012","unstructured":"Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, et al. Amyloid-\u03b2 assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology. 2012;79:1636\u201344. https:\/\/doi.org\/10.1212\/WNL.0b013e3182661f74.","journal-title":"Neurology"},{"key":"7080_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1212\/WNL.0b013e318246d67a","volume":"78","author":"G Ch\u00e9telat","year":"2012","unstructured":"Ch\u00e9telat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, et al. Accelerated cortical atrophy in cognitively normal elderly with high \u03b2-amyloid deposition. Neurology. 2012;78:477\u201384. https:\/\/doi.org\/10.1212\/WNL.0b013e318246d67a.","journal-title":"Neurology"},{"key":"7080_CR59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/s1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic alzheimer\u2019s disease: A prospective cohort study. Lancet Neurol. 2013;12:357\u201367. https:\/\/doi.org\/10.1016\/s1474-4422(13)70044-9.","journal-title":"Lancet Neurol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07080-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:55:30Z","timestamp":1739962530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07080-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7080"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07080-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ADNI study received approval from the Institutional Review Boards (IRBs) of all participating centers. Written  informed consent was obtained from all participants or their legally authorized representatives. The Huashan cohort  study was approved by the Ethics Committees of Huashan Hospital and the Sixth People\u2019s Hospital affiliated to Shanghai  Jiao Tong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"This manuscript has been seen and approved by all authors. All authors declare no conflict of interest that may directly  or indirectly influence the content of the manuscript submitted. Author Fang Xie is an editor of this journal. However,  this does not affect the objectivity or integrity of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement"}}]}}